Chest-indrawing pneumonia Respiratory
Conditions
Interventions
The scope of this study is to understand the current management and outcomes for children 2-59 months of age with chest-indrawing pneumonia presenting at primary-level healthcare facilities in high-bu
Sponsors
World Health Organization
Eligibility
Sex/Gender
All
Age
2 Months to 59 Months
Inclusion criteria
Inclusion criteria: 1. Age 2-59 months old 2. Living in a geographic area where follow-up for 15 days can be accomplished 3. Presenting to a first-level health facility with chest-indrawing pneumonia
Exclusion criteria
Exclusion criteria: 1. Age 5 years 2. Any general danger signs (convulsion, inability to drink or breastfeed, vomiting everything, lethargic/unconscious) 3. Stridor in a calm child 4. Oxygen saturation (SpO2) <90% 5. Currently included in any other study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival status of 2-59 month-old children with chest-indrawing pneumonia who presented at the primary health care facility in a programme setting measured using the information provided by the caregivers by day 15 | — |
Secondary
| Measure | Time frame |
|---|---|
| The management (including oral treatment, which one, for how many days, or hospitalisation, with injectable antibiotics, how many days, and treatment adherence) of children 2-59 months of age with chest-indrawing pneumonia presenting at the primary health care facility in a programme setting measured using the information provided by the caregiver, medical records, and the availability of medicines or any prescription at day 15 | — |
Countries
Ethiopia, India, Nigeria, Pakistan, Uganda, Zambia
Contacts
Public ContactYasir Bin Nisar
Outcome results
None listed